Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Minjie Jiang"'
Autor:
Juan Li, Minjie Jiang, Xin Hua, Hongxia Xu, Muchen Wu, Jing Wu, Songtao Liu, Hanping Shi, Qinghua Meng
Publikováno v:
BMC Gastroenterology, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background The Global Leadership Initiative on Malnutrition criteria (GLIM) was established to build a global consensus on the diagnostic criteria for malnutrition. The study aimed to assess the prevalence of the malnutrition diagnosed by GL
Externí odkaz:
https://doaj.org/article/7440e648a0f5403aadebd4e99f23803c
Autor:
Xiaotong Xu, Changyou Jing, Tong Zhu, Minjie Jiang, Yunlai Fu, Fang Xie, Jianjun Li, Qinghua Meng
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
This patient was an elderly patient with abdominal distension and shortness of breath. According to relevant examinations, his condition was initially considered to be related to cirrhosis, but pathological biopsy confirmed the diagnosis of noncirrho
Externí odkaz:
https://doaj.org/article/47ac0bcf2bb3495f9083b6f63707d40d
Publikováno v:
Journal of Orthopaedic Surgery and Research, Vol 19, Iss 1, Pp 1-17 (2024)
Abstract Purpose Patients are typically diagnosed with both hypertension and fibrosarcoma. Medical oncologists must prescribe suitable anti-hypertensive medications while considering anti-tumor drugs. Recently, immunotherapy has become prominent in c
Externí odkaz:
https://doaj.org/article/5b9d28cd90354c4da039289075527c0f
Autor:
Minjie Jiang, Juan Chen, Muchen Wu, Jing Wu, Xiaotong Xu, Juan Li, Can Liu, Yaping Zhao, Xin Hua, Qinghua Meng, Yanjie Yin
Publikováno v:
Chinese Medical Journal, Vol 137, Iss 1, Pp 97-104 (2024)
Abstract. Background:. The Global Leadership Initiative on Malnutrition (GLIM) criteria were published to build a global consensus on nutritional diagnosis. Reduced muscle mass is a phenotypic criterion with strong evidence to support its inclusion i
Externí odkaz:
https://doaj.org/article/40213fadfa7d416cad33348cd9f218eb
Autor:
Muchen Wu, Jing Wu, Kai Liu, Minjie Jiang, Fang Xie, Xuehong Yin, Jushan Wu, Qinghua Meng, Yanjie Yin
Publikováno v:
Chinese Medical Journal, Vol 137, Iss 2, Pp 190-199 (2024)
Abstract. Background:. Acute-on-chronic liver failure (ACLF) is a severe liver disease with complex pathogenesis. Clinical hypoglycemia is common in patients with ACLF and often predicts a worse prognosis. Accumulating evidence suggests that glucose
Externí odkaz:
https://doaj.org/article/b2ca1e39b3ec4e69bd514149f49229f9
Publikováno v:
Frontiers in Nutrition, Vol 11 (2024)
BackgroundSarcopenia is common in patients with liver cirrhosis and is an independent predictor of multiple clinical outcomes. Most studies to date have used a static assessment of sarcopenia. However, there is very limited data evaluating the tempor
Externí odkaz:
https://doaj.org/article/23f644340a5d468ebf56e94c15f4eb87
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Introduction: Transjugular intrahepatic portosystemic shunt (TIPS) is an effective way to improve portal hypertension, however, the role of anticoagulation or antiplatelet therapy following TIPS remains controversial. We conducted this study to evalu
Externí odkaz:
https://doaj.org/article/08a2a31de8ec4e7b9f5fde1b6955f8bc
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Backgrounds: Kidney biomarkers in urine appear to be useful in differential diagnosis between acute tubular necrosis and other types of acute kidney injury (AKI) in cirrhosis. In clinical practice, prerenal azotemia (PRA) is often distinguished from
Externí odkaz:
https://doaj.org/article/f8561cb1f5bf48ce993735f23d4ffec9
Publikováno v:
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background and aims Liver enzymes, including alanine aminotransferase (ALT) and aspartate aminotransferase (AST), are markers of hepatic dysfunction and fatty liver disease. Although ALT and AST have been suggested as risk factors for cardio
Externí odkaz:
https://doaj.org/article/04189053362049dca47e2cc0b448f78f
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
The prevalence and incidence of metabolic-associated fatty liver disease (MAFLD), a clinically heterogeneous disease whose primary clinical therapies include dietary control and exercise therapy, is increasing worldwide and constitutes a significant
Externí odkaz:
https://doaj.org/article/103c2234410648a3b054a6a1d10e771b